It was asked on Stockhouse who CD  Ventures is. They are a German Vencap fund. Managing director is Christoph Boehringer (Boehringer Engelheim).  I've typed more about them before.

I noticed today that Sarepta sold a Priority Review Voucher (the correct term for "coupon" - don't know why DM calls it that) to Gilead for $125M.  Obviously still a market for PRV's, not sure if RVX is still thinking that is a possibility for us.

Since Im typing, I noticed short interest was up by almost 60k shares to just over 200k total. Still only just under .2% of the float